For first-year college students, going to a school away from home and the norm of their parents and friends can be a hard adjustment. In addition to…
Read Article
ÌÇÐÄlogo today announced that a new research agreement with United Therapeutics Corporation (Nasdaq: UTHR), a public benefit…
Read Article
A study published in Nature Cell Biology reports a new vulnerability in acute myeloid leukemia (AML) that might lead to novel therapies to treat this…
Read Article
A team of epidemiologists, infectious disease researchers, climatologists and educators from ÌÇÐÄlogo, Rice University and the…
Read Article
Researchers at ÌÇÐÄlogo have developed a drug called CS18 that disrupts the ability of cancer cells to survive therapy. The…
Read Article
Movement is crucial for the body and benefits overall health, but going to the gym is not for everyone. Some prefer to play sports while others might…
Read Article
With the expansion of commercial spaceflight, researchers have an unprecedented opportunity to better understand how space travel affects human…
Read Article
After more than 15 years of collaborative research, ÌÇÐÄlogo (BCM) and Houston Zoo have reached a major milestone in the fight…
Read Article
Every person's DNA tells a unique story. To unlock the full potential of genetic research, scientists need tools that reflect the complexity of…
Read Article
Many neurological diseases damage specific parts of the brain, even though the harmful protein involved is present throughout the brain. Researchers…
Read Article
ÌÇÐÄlogo, in affiliation with Texas Children’s Hospital, is marking 10 years as part of the SPARK Clinical Site Network. SPARK…
Read Article
ÌÇÐÄlogo researchers played a key role in the clinical development of the first oral PCSK9 inhibitor approved by the U.S. Food and…
Read Article
Cyclosporiasis, a parasite causing ‘explosive diarrhea,’ is making headlines across the country. Dr. Stacey Rose, associate professor of internal…
Read Article
Researchers have uncovered a novel biological pathway that can lead to seizures when disrupted. The findings also provide a new approach to improve…
Read Article
…
Loss of one copy of the DNA Ligase I (LIG1) gene in triple-negative breast cancers (TNBC) with TP53 mutations confers resistance to chemotherapy, but…
Read Article
ÌÇÐÄlogo’s Human Genome Sequencing Center will serve as the clinical sequencing center for the new Population Genomic Screening…
Read Article